drugset / Trial / NCT00109655
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The main purpose of this research study is to evaluate the safety and dosing of CG0070.
Timeline
- Start
- 2005-04
- Primary completion
- 2008-10
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cretostimogene Grenadenorepvec | Unknown | — | Other |